Profound Medical Stock Alert: Company Reports Error which Overstated Revenue - Kehoe Law Firm, P.C. Investigating - PROF

Philadelphia, Pennsylvania--(Newsfile Corp. - March 13, 2025) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Profound Medical Corp. ("Profound Medical," "Profound," or the "Company") (NASDAQ: PROF).

In a March 7, 2025 Form 8-K, Profound Medical reported that "[i]n conjunction with the Company's transition to U.S. GAAP, the Audit Committee of Profound's Board of Directors . . ., after discussion with Profound's auditors, . . . identified an error which overstated revenue by $472,000 in the first quarter of 2024."

As a result of the Company's error, Profound also reported that its ". . . previously issued 2024 Interim Financial Statements . . . will be restated and reissued and should no longer be relied upon[,]" as well as that . . . any previously filed or furnished reports, related earnings releases, related management's discussion and analysis, investor presentations or similar communications of Profound describing Profound's financial results or other financial information for the quarters of 2024, and any previously issued forecast or guidance for the fiscal year ended December 31, 2024, should no longer be relied upon."

On this news, Profound Medical's stock price dropped almost 6%, closing at $6.86 per share on March 7, 2025.

Profound Medical Investors interested in learning more about the securities fraud investigation can complete Kehoe Law Firm's Stockholder Information Request form or send us a message to contact an attorney for a free, no-obligation legal evaluation.

If necessary, Profound shareholders should copy/paste either https://kehoelawfirm.com/stockholder-information-request/ or https://kehoelawfirm.com/contact/ into their web browser.

ABOUT KEHOE LAW FIRM, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

We litigate securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

This press release may constitute attorney advertising.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/244445